ICLR - Icon Plc
IEX Last Trade
322.04
1.460 0.453%
Share volume: 446,095
Last Updated: Fri 30 Aug 2024 09:59:53 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$320.58
1.46
0.46%
View ratios
Fiscal Date | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-06-30 | |
---|---|---|---|---|---|---|---|---|---|
Fiscal Quarter | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | |
Report Date | 2022-11-02 | 2023-02-24 | 2023-04-26 | 2023-07-26 | 2023-10-25 | 2024-02-23 | 2024-04-24 | 2024-07-24 | |
Assets | |||||||||
Total Assets | 17.126 B | 17.185 B | 17.287 B | 17.108 B | 17.031 B | 16.990 B | 17.048 B | 16.969 B | |
Current Assets | 3.172 B | 3.229 B | 3.429 B | 3.368 B | 3.421 B | 3.411 B | 3.555 B | 3.604 B | |
Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Other Current Assets | 129.218 M | 137.094 M | 170.167 M | 152.774 M | 150.193 M | 132.105 M | 149.127 M | 139.244 M | |
Short Term Investments | 129.218 M | 137.094 M | 170.167 M | 152.774 M | 150.193 M | 132.105 M | 149.127 M | 139.244 M | |
Total Receivables | 2.431 B | 2.801 B | 2.978 B | 2.943 B | 2.956 B | 2.899 B | 3.008 B | 2.958 B | |
Current Cash | 610.870 M | 290.481 M | 281.533 M | 271.829 M | 315.019 M | 380.056 M | 398.037 M | 506.553 M | |
Total Non-current Assets | 13.954 B | 13.956 B | 13.857 B | 13.740 B | 13.610 B | 13.578 B | 13.493 B | 13.365 B | |
Property Plant Equipment | 315.524 M | 350.320 M | 348.106 M | 346.521 M | 342.262 M | 361.184 M | 353.302 M | 353.844 M | |
Other Assets | 77.260 M | 92.170 M | 93.688 M | 89.309 M | 93.278 M | 78.470 M | 87.193 M | 87.609 M | |
Intangible Assets | 4.392 B | 4.279 B | 4.164 B | 4.050 B | 3.935 B | 3.856 B | 3.749 B | 3.632 B | |
Goodwill | 8.943 B | 8.972 B | 8.979 B | 8.994 B | 8.983 B | 9.022 B | 9.018 B | 9.017 B | |
Liabilities and shareholders’ equity | |||||||||
Total Liabilities and shareholders’ equity | 17.126 B | 17.185 B | 17.287 B | 17.108 B | 17.031 B | 16.990 B | 17.048 B | 16.969 B | |
Total liabilities | 8.887 B | 8.687 B | 8.633 B | 8.311 B | 8.072 B | 7.749 B | 7.616 B | 7.384 B | |
Total current liabilities | 2.731 B | 2.691 B | 2.899 B | 2.760 B | 2.871 B | 2.826 B | 2.946 B | 2.742 B | |
Accounts Payable | 60.851 M | 81.194 M | 85.126 M | 46.920 M | 87.317 M | 131.584 M | 113.579 M | 83.037 M | |
Other liabilities | 260.532 M | 277.448 M | 289.990 M | 280.848 M | 284.633 M | 232.652 M | 234.864 M | 244.150 M | |
Current long term debt | 55.150 M | 55.150 M | 135.150 M | 105.150 M | 130.150 M | 110.150 M | 79.762 M | 29.762 M | |
Long term debt | 4.795 B | 4.599 B | 4.354 B | 4.207 B | 3.912 B | 3.665 B | 3.420 B | 3.408 B | |
Other liabilities | 260.532 M | 277.448 M | 289.990 M | 280.848 M | 284.633 M | 232.652 M | 234.864 M | 244.150 M | |
Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Total Shareholder equity | 8.239 B | 8.498 B | 8.654 B | 8.796 B | 8.959 B | 9.241 B | 9.433 B | 9.585 B | |
Common stock | 81.582 M | 81.686 M | 81.784 M | 82.000 M | 82.216 M | 82.407 M | 82.579 M | 82.739 M | |
Retained earnings | 1.704 B | 1.821 B | 1.938 B | 2.054 B | 2.217 B | 2.434 B | 2.621 B | 2.768 B |